Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Perspective: Checking in with a prescriber of Beyfortus (nirsevimab) for newborns and infants to prevent RSV-related lower respiratory tract disease.

Ticker(s): AZN, SNY

Who's the expert?

Institution: Optum

Urgent Care Lead Clinician at Optum
Familiar with the phase 3 MenABCWY Noninferiority study
Manages 10 patients in the ER with Meningitis

Interview Goal

to discuss the current treatment landscape and the use of Beyfortus (nirsevimab) a long-acting monoclonal antibody that's given to newborns and infants as a single dose to help prevent RSV-related lower respiratory tract disease

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.